NASP Responds to FTC Findings and Reiterates Plea: Specialty Pharmacies and Their Patients Can’t Continue to Wait for PBM Reform-Related Pharmacy Protections Washington, DC, Jan. 15, 2025 (GLOBE NEWSWIRE) -- The National Association of Specialty Pharmacy (NASP) issued the following statement after the Federal Trade Commission (FTC) published a second...

NASP Responds to FTC Findings and Reiterates Plea: Specialty Pharmacies and Their Patients Can’t Continue to Wait for PBM Reform-Related Pharmacy Protections Washington, DC, Jan. 15, 2025 (GLOBE NEWSWIRE) -- The National Association of Specialty Pharmacy (NASP) issued the following statement after the Federal Trade Commission (FTC) published a second...

NASP Tells Congress and the Incoming Trump Administration: Pharmacies and Patients Can’t Continue to Wait for PBM Reform-Related Pharmacy Protections Washington, DC, Dec. 21, 2024 (GLOBE NEWSWIRE) -- The National Association of Specialty Pharmacy issued the following statement: As the non-profit trade organization representing specialty...